DC District Court overturns HRSA’s 340B guidance on orphan drug exclusion, applying less deference to the agency’s interpretation of the 340B statute; possible implications for proposed mega-guidance.
DC District Court overturns HRSA’s 340B guidance on orphan drug exclusion, applying less deference to the agency’s interpretation of the 340B statute; possible implications for proposed mega-guidance.